FAU researchers and their colleagues at the University of Bayreuth investigated whether an artificial silk protein developed in the laboratory could be suitable for engineering cardiac tissue.
Neuroscientists have joined forces with human geneticists at Otto von Guericke University in Magdeburg to develop a new approach to the treatment of rare genetic conditions such as Noonan syndrome.
In future, researchers in Erlangen will take into account a little-noted factor in the development of diseases: physics.
The Digital Health Innovation Platform (d.hip) was established by an alliance between university medicine, industry, and science for the purpose of accelerating the digitalization of medicine and healthcare.
Eleven German biobank sites are joining forces in the German Biobank Alliance, smoothing the way for a national and Europe-wide exchange of data and bio-samples. The Chair of Medical Informatics is one of the IT centres of expertise in the network.
Pancreatic cancer is one of the most aggressive types of tumour because it starts forming metastases early. The cancer itself, however, is usually only discovered late. Researchers at the Chair of Experimental Medicine I have just discovered why pancreatic cancer and other malignant types of tumors can proliferate so rapidly.
We've all heard it: eating salty foods makes you thirstier. But what sounds like good nutritional advice turns out to be an old-wives' tale. In a study carried out during a simulated mission to Mars, an international group of scientists has found exactly the opposite to be true. “Cosmonauts” who ate more salt retained more water, weren't as thirsty, and needed more energy.
The Faculty of Medicine is glad to welcome another scholar from the Alexander von Humboldt Foundation at the Chair of Anatomy II: As part of his Humboldt Research Fellowship for experienced researchers, Dr. Mohammed Javed Ali aims to better understand the function and pathophysiology of the nasolacrimal ducts.
The Department of Medicine 4 is a member of a worldwide consortium that has the aim of improving treatment of chronic kidney disease.
Researchers at the Department of Neurology demonstrated the significant influence of new signal paths of the renin-angiotensin system (RAS).